At a glance
- Originator Wyeth
- Class Heart failure therapies
- Mechanism of Action Phosphoric diester hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 31 Oct 2000 No-Development-Reported for Heart failure in USA (Unknown route)